ANZICS CTG Endorsed Study

FLASH

FLudrocortisone administration in Aneurysmal Subarachnoid Haemorrhage The FLASH Trial.

A prospective, blinded, randomised clinical trial of fludrocortisone compared with placebo in critically ill patients presenting with aneurysmal subarachnoid haemorrhage . To determine whether administration of enteral fludrocortisone in aneurysmal subarachnoid haemorrhage will reduce death and dependency at six months

Study Description

A multi-centre, prospective, blinded, randomised clinical trial. To determine whether administration of enteral fludrocortisone in aneurysmal subarachnoid haemorrhage will reduce death and dependency at six months.

Management Committee

Jeremy Cohen, Anthony Delaney, Malcolm Fisher, Tessa Garside, Naomi Hammond, Serena Knowles, Melissa Lassig-Smith, Gladness Nethathe, Dorrilyn Rajbhandari, Philip Talbot, Bala Venkatesh, Paul Young, Jason Wright, Miranda Hardie

Administering Institution

The George Institute for Global Health

Sample Size

524 patients

Funding

MRFF

Reference

CTG2425-01, NCT06409364

Contact

Miranda Hardie (email) or flash-study@georgeinstitute.org.au